XML 75 R46.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders Equity (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Weighted Average Assumptions
The following weighted average assumptions were used for grants during the following periods:
Years ended December 31,
20242023
Dividend Yield0.00%n/a
Volatility74.72%n/a
Risk-Free Interest Rate4.17%n/a
Expected Life3.50 yearsn/a
Schedule of Stock Options Activity
A summary of stock option activity under the Company’s 2014 Plan and 2024 Plan for the year ended December 31, 2024 is as follows:
Stock OptionsNumber of Shares Weighted Average Exercise
Price per Share
 Weighted Average Remaining
Contractual Term
 Aggregate Intrinsic Value
  
Outstanding at January 1, 2024107,201$8.31 0.94$
     
Granted318,750$2.25 4.07$4,124,625 
Exercised(84,038)$8.42 -$166,145 
Expired/Forfeited(60,000)$2.25 4.55$241,900 
     
Outstanding at December 31, 2024281,913$2.71 3.74$3,517,111 
     
Vested and Exercisable at December 31, 202423,163$7.90 0.10$168,886 
Schedule of the Restricted Common Stock Activity
A summary of the restricted Common Stock activity under the Company’s 2014 Plan and 2024 Plan for the year ended December 31, 2024 is as follows:
Restricted Stock AwardsShares Weighted Average Grant Date Fair Value per Share Aggregate
Fair Value
   
Balance at January 1, 2024550,581$3.82 $2,103,219 
    
Granted237,214$5.52 $1,308,699 
Vested(517,709)$3.86 $(1,998,357)
Forfeited(2,500)$4.80 $(12,000)
    
Balance at December 31, 2024267,586$5.24 $1,402,151